Literature DB >> 15923186

Hirudin binding reveals key determinants of thrombin allostery.

Kristen E Mengwasser1, Leslie A Bush, Peter Shih, Angelene M Cantwell, Enrico Di Cera.   

Abstract

Thrombin exists in two allosteric forms, slow (S) and fast (F), that recognize natural substrates and inhibitors with significantly different affinities. Because under physiologic conditions the two forms are almost equally populated, investigation of thrombin function must address the contribution from the S and F forms and the molecular origin of their differential recognition of ligands. Using a panel of 79 Ala mutants, we have mapped for the first time the epitopes of thrombin recognizing a macromolecular ligand, hirudin, in the S and F forms. Hirudin binding is a relevant model for the interaction of thrombin with fibrinogen and PAR1 and is likewise influenced by the allosteric S-->F transition. The epitopes are nearly identical and encompass two hot spots, one in exosite I and the other in the Na+ site at the opposite end of the protein. The higher affinity of the F form is due to the preferential interaction of hirudin with Lys-36, Leu-65, Thr-74, and Arg-75 in exosite I; Gly-193 in the oxyanion hole; and Asp-221 and Asp-222 in the Na+ site. Remarkably, no correlation is found between the energetic and structural involvements of thrombin residues in hirudin recognition, which invites caution in the analysis of protein-protein interactions in general.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923186     DOI: 10.1074/jbc.M502678200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold.

Authors:  Austin D Vogt; Pradipta Chakraborty; Enrico Di Cera
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

2.  Structural identification of the pathway of long-range communication in an allosteric enzyme.

Authors:  Prafull S Gandhi; Zhiwei Chen; F Scott Mathews; Enrico Di Cera
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

3.  Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin.

Authors:  Chang C Liu; Eric Brustad; Wenshe Liu; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2007-08-09       Impact factor: 15.419

4.  Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.

Authors:  Madhavi A Jadhav; R Cory Lucas; Whitney N Goldsberry; Muriel C Maurer
Journal:  Biochim Biophys Acta       Date:  2011-07-21

5.  Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.

Authors:  Madhavi A Jadhav; Whitney N Goldsberry; Sara E Zink; Kelsey N Lamb; Katelyn E Simmons; Carmela M Riposo; Boris A Anokhin; Muriel C Maurer
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-07-04       Impact factor: 3.036

6.  Ligand binding to anion-binding exosites regulates conformational properties of thrombin.

Authors:  Marina V Malovichko; T Michael Sabo; Muriel C Maurer
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

7.  A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin.

Authors:  Daniel K Afosah; Stephen Verespy; Rami A Al-Horani; Rio S Boothello; Rajesh Karuturi; Umesh R Desai
Journal:  Bioorg Med Chem Lett       Date:  2018-02-03       Impact factor: 2.823

8.  Thrombin allosteric modulation revisited: a molecular dynamics study.

Authors:  Hermes Luís Neubauer de Amorim; Paulo Augusto Netz; Jorge Almeida Guimarães
Journal:  J Mol Model       Date:  2009-10-09       Impact factor: 1.810

Review 9.  Thrombin.

Authors:  Enrico Di Cera
Journal:  Mol Aspects Med       Date:  2008-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.